Evidence map›Paper›PMID 23709655›Full record

Trial reportThe Journal of clinical endocrinology and metabolism2013

Sex hormone binding globulin and sex steroids among premenopausal women in the diabetes prevention program.

Catherine Kim, Xavier Pi-Sunyer, Elizabeth Barrett-Connor, Frankie B Stentz, Mary Beth Murphy, Shengchun Kong, Bin Nan, Abbas E Kitabchi, Diabetes Prevention Program Research Group

Open access · bronzeAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of clinical endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Lifestyle changes in women with polycystic ovary syndrome.The Cochrane database of systematic reviews · 2019
    Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Catherine KimUniversity of Michigan, Ann Arbor, Michigan 48109-2800, USA. cathkim@umich.edu
Xavier Pi-Sunyer
Elizabeth Barrett-Connor
Frankie B Stentz
Mary Beth Murphy
Shengchun Kong
Bin Nan
Abbas E Kitabchi
Diabetes Prevention Program Research Group
University of Michigan–Ann Arbor · USUniversity of Tennessee Health Science Center · USColumbia University · USUniversity of California, San Diego · US

Funding

PRIMARY PREVENTION TRIAL--DATA COORDINATING CENTERU01DK048489 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI JABLONSKI, KATHLEEN ANN, TEMPROSA, MARINELLA · 1994 to 2021
$84.8M
Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Karin E Bornfeldt · 1986 to 2026
$41.4M
UNM HSC Clinical and Translational Science CenterUL1TR001449 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI CAMPEN, MATTHEW J, PANDHI, NANCY · 2015 to 2024
$36.9M
Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
University of New Mexico Clinical and Translational Science CenterUL1TR000041 · NCATS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LARSON, RICHARD S · 2012 to 2014
$9.8M
USE OF MOTIVATIONAL INTERVIEWING TO MANAGE TYPE I DIABETESM01RR000211 · NCRR · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KITABCHI, ABBAS E. · 1985 to 2006
$9.6M
Sex Hormones in Postmenopausal Women in the Diabetes Prevention ProgramR01DK083297 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CATHERINE · 2010 to 2012
$1.1M
MECHANISMS OF ACTION IN DPP INTERVENTIONSR01DK053061 · NIDDK · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI KITABCHI, ABBAS E. · 1998 to 2001
$988k
Type 2 Diabetes Risk in Women With Gestational DiabetesK23DK071552 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KIM, CATHERINE · 2006 to 2010
$674k
Intramural NIH HHSNCATS NIH HHS UL1 TR000041NCATS NIH HHS UL1 TR001449NCRR NIH HHS GCRC RR00211NCRR NIH HHS M01 RR000211NIDDK NIH HHS K23 DK071552NIDDK NIH HHS K23DK071552NIDDK NIH HHS P30 DK017047NIDDK NIH HHS P30 DK020572NIDDK NIH HHS R01 DK053061NIDDK NIH HHS R01 DK083297NIDDK NIH HHS R01DK083297NIDDK NIH HHS R01DK53061NIDDK NIH HHS U01 DK048489NIDDK NIH HHS U01DK048489
6 · The paper itself

Abstract

contextIt is unknown whether intensive lifestyle modification (ILS) or metformin changes sex steroids among premenopausal women without a history of polycystic ovarian syndrome (PCOS).

objectivesWe examined 1-year intervention impact on sex steroids (estradiol, testosterone, dehydroepiandrosterone, and androstenedione [A4]) and SHBG and differences by race/ethnicity.

participantsA subgroup of Diabetes Prevention Program participants who were premenopausal, not using estrogen, without a history of PCOS or irregular menses, and who reported non-Hispanic white (NHW), Hispanic, or African-American race/ethnicity (n = 301).

interventionsRandomization arms were 1) ILS with the goals of weight reduction of 7% of initial weight and 150 minutes per week of moderate intensity exercise, 2) metformin 850 mg twice a day, or 3) placebo.

resultsNeither intervention changed sex steroids compared to placebo. ILS, but not metformin, increased median SHBG by 3.1 nmol/L (~11%) compared to decreases of 1.1 nmol/L in the placebo arm (P < .05). This comparison remained significant after adjustment for changes in covariates including waist circumference. However, associations with glucose were not significant. Median baseline A4 was lower in Hispanics compared to NHWs (5.7 nmol/L vs 6.5 nmol/L, P < .05) and increases in A4 were greater in Hispanics compared to NHWs (3.0 nmol/ vs 1.2 nmol/L, P < .05), and these differences did not differ significantly by intervention arm. No other racial/ethnic differences were significant.

conclusionsAmong premenopausal glucose-intolerant women, no intervention changed sex steroids. ILS increased SHBG, although associations with glucose were not significant. SHBG and sex steroids were similar by race/ethnicity, with the possible exception of lower baseline A4 levels in Hispanics compared to NHWs.

Indexed as

Diet, ReducingExerciseAdultBlack or African AmericanBody Mass IndexCombined Modality TherapyDiabetes MellitusEstradiolFemaleFollow-Up StudiesGlucose IntoleranceHispanic or LatinoHumansHypoglycemic AgentsMetforminMiddle AgedEstradiolHypoglycemic AgentsMetforminSex Hormone-Binding GlobulinTestosterone Congeners

Identifiers

PMID23709655
PMCPMC3701280
OpenAlexW2004475022

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.